100 related articles for article (PubMed ID: 32386023)
1. High glucose up
Tang L; Xu Y; Liu X; Chen R; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):305-313. PubMed ID: 32386023
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated PKM2 regulates endothelium-dependent vasodilation in diabetes.
Lu B; Tang L; Li L; Zhou X; Leng Y; Quan C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):663-670. PubMed ID: 37539568
[TBL] [Abstract][Full Text] [Related]
3. Gene Regulatory Effect of Pyruvate Kinase M2 is Involved in Renal Inflammation in Type 2 Diabetic Nephropathy.
Li L; Tang L; Yang X; Chen R; Zhang Z; Leng Y; Chen AF
Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):599-606. PubMed ID: 31958846
[TBL] [Abstract][Full Text] [Related]
4. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
5. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Das G; Shiras A; Shanmuganandam K; Shastry P
Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway.
Sun JJ; Yin XW; Liu HH; Du WX; Shi LY; Huang YB; Wang F; Liu CF; Cao YJ; Zhang YL
Acta Pharmacol Sin; 2018 Mar; 39(3):336-344. PubMed ID: 29072256
[TBL] [Abstract][Full Text] [Related]
7. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
[TBL] [Abstract][Full Text] [Related]
8. mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway.
Yang HW; Hong HL; Luo WW; Dai CM; Chen XY; Wang LP; Li Q; Li ZQ; Liu PQ; Li ZM
Acta Pharmacol Sin; 2018 Dec; 39(12):1837-1846. PubMed ID: 29991711
[TBL] [Abstract][Full Text] [Related]
9. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
Kumar B; Bamezai RN
Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825
[TBL] [Abstract][Full Text] [Related]
10. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
[TBL] [Abstract][Full Text] [Related]
12. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
Cheng K; Hao M
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
14. Metabolic regulation of T cell development by Sin1-mTORC2 is mediated by pyruvate kinase M2.
Ouyang X; Han Y; Qu G; Li M; Wu N; Liu H; Arojo O; Sun H; Liu X; Liu D; Chen L; Zou Q; Su B
J Mol Cell Biol; 2019 Feb; 11(2):93-106. PubMed ID: 30428057
[TBL] [Abstract][Full Text] [Related]
15. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of microRNA-424 relieved diabetic nephropathy by targeting Rictor through mTOR Complex2/Protein Kinase B signaling.
Wang G; Yan Y; Xu N; Hui Y; Yin D
J Cell Physiol; 2019 Jul; 234(7):11646-11653. PubMed ID: 30637733
[TBL] [Abstract][Full Text] [Related]
17. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
[TBL] [Abstract][Full Text] [Related]
18. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
Li S; Ji X; Wang R; Miao Y
Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
Zheng B; Wang J; Tang L; Shi J; Zhu D
Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
Sun H; Zhu A; Zhang L; Zhang J; Zhong Z; Wang F
Int J Mol Sci; 2015 Oct; 16(10):24574-87. PubMed ID: 26501265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]